{"id":795687,"date":"2024-12-18T07:04:52","date_gmt":"2024-12-18T12:04:52","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/oruka-therapeutics-to-be-added-to-the-nasdaq-biotechnology-index-nbi\/"},"modified":"2024-12-18T07:04:52","modified_gmt":"2024-12-18T12:04:52","slug":"oruka-therapeutics-to-be-added-to-the-nasdaq-biotechnology-index-nbi","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/oruka-therapeutics-to-be-added-to-the-nasdaq-biotechnology-index-nbi\/","title":{"rendered":"Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI)"},"content":{"rendered":"
\n

MENLO PARK, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) — Oruka Therapeutics, Inc. (\u201cOruka\u201d) (Nasdaq: ORKA), a biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including plaque psoriasis, today announced that it is expected to be added to the Nasdaq Biotechnology Index (Nasdaq: NBI) (the \u201cNBI\u201d). Oruka\u2019s addition will become effective prior to market open on Monday, December 23rd<\/sup>, 2024.<\/p>\n

The NBI is designed to track the performance of a set of securities listed on\u00a0The Nasdaq Stock Market\u00a0that are issued by companies classified as either biotechnology or pharmaceutical companies according to the Industry Classification Benchmark. Companies in the NBI must meet certain eligibility requirements, including, but not limited to, minimum market capitalization, average daily trading volume, and seasoning as a public company. The NBI is evaluated annually in December and is calculated under a modified capitalization-weighted methodology.<\/p>\n

For more information about the NBI, visit:\u00a0https:\/\/indexes.nasdaqomx.com\/Index\/Overview\/NBI<\/a><\/p>\n

\n About Oruka Therapeutics<\/strong>\n <\/p>\n

Oruka Therapeutics is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. Oruka\u2019s mission is to offer patients suffering from chronic skin diseases like plaque psoriasis the greatest possible freedom from their condition by achieving high rates of complete disease clearance with dosing as infrequently as once or twice a year. Oruka is advancing a proprietary portfolio of potentially best-in-class antibodies that were engineered by Paragon Therapeutics and target the core mechanisms underlying plaque psoriasis and other dermatologic and inflammatory diseases. For more information, visit www.orukatx.com<\/a> and follow Oruka on LinkedIn.<\/p>\n

\n Investor Contact:\u00a0<\/strong>
\n
Alan Lada\u00a0
(650)-606-7911\u00a0
alan.lada@orukatx.com\u00a0<\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

MENLO PARK, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) — Oruka Therapeutics, Inc. (\u201cOruka\u201d) (Nasdaq: ORKA), a biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including plaque psoriasis, today announced that it is expected to be added to the Nasdaq Biotechnology Index (Nasdaq: NBI) (the \u201cNBI\u201d). Oruka\u2019s addition will become effective prior to market open on Monday, December 23rd, 2024. The NBI is designed to track the performance of a set of securities listed on\u00a0The Nasdaq Stock Market\u00a0that are issued by companies classified as either biotechnology or pharmaceutical companies according to the Industry Classification Benchmark. Companies in the NBI must meet certain eligibility requirements, including, but not limited to, minimum market … <\/p>\n

Continue reading “Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI)”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-795687","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nOruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI) - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/oruka-therapeutics-to-be-added-to-the-nasdaq-biotechnology-index-nbi\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI) - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MENLO PARK, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) — Oruka Therapeutics, Inc. (\u201cOruka\u201d) (Nasdaq: ORKA), a biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including plaque psoriasis, today announced that it is expected to be added to the Nasdaq Biotechnology Index (Nasdaq: NBI) (the \u201cNBI\u201d). Oruka\u2019s addition will become effective prior to market open on Monday, December 23rd, 2024. The NBI is designed to track the performance of a set of securities listed on\u00a0The Nasdaq Stock Market\u00a0that are issued by companies classified as either biotechnology or pharmaceutical companies according to the Industry Classification Benchmark. Companies in the NBI must meet certain eligibility requirements, including, but not limited to, minimum market … Continue reading "Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI)"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/oruka-therapeutics-to-be-added-to-the-nasdaq-biotechnology-index-nbi\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-18T12:04:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyMDg4NiM2NjQyMjA3IzIyOTAwOTk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oruka-therapeutics-to-be-added-to-the-nasdaq-biotechnology-index-nbi\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oruka-therapeutics-to-be-added-to-the-nasdaq-biotechnology-index-nbi\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI)\",\"datePublished\":\"2024-12-18T12:04:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oruka-therapeutics-to-be-added-to-the-nasdaq-biotechnology-index-nbi\\\/\"},\"wordCount\":285,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oruka-therapeutics-to-be-added-to-the-nasdaq-biotechnology-index-nbi\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyMDg4NiM2NjQyMjA3IzIyOTAwOTk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oruka-therapeutics-to-be-added-to-the-nasdaq-biotechnology-index-nbi\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oruka-therapeutics-to-be-added-to-the-nasdaq-biotechnology-index-nbi\\\/\",\"name\":\"Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI) - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oruka-therapeutics-to-be-added-to-the-nasdaq-biotechnology-index-nbi\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oruka-therapeutics-to-be-added-to-the-nasdaq-biotechnology-index-nbi\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyMDg4NiM2NjQyMjA3IzIyOTAwOTk=\",\"datePublished\":\"2024-12-18T12:04:52+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oruka-therapeutics-to-be-added-to-the-nasdaq-biotechnology-index-nbi\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oruka-therapeutics-to-be-added-to-the-nasdaq-biotechnology-index-nbi\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oruka-therapeutics-to-be-added-to-the-nasdaq-biotechnology-index-nbi\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyMDg4NiM2NjQyMjA3IzIyOTAwOTk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyMDg4NiM2NjQyMjA3IzIyOTAwOTk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oruka-therapeutics-to-be-added-to-the-nasdaq-biotechnology-index-nbi\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI) - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/oruka-therapeutics-to-be-added-to-the-nasdaq-biotechnology-index-nbi\/","og_locale":"en_US","og_type":"article","og_title":"Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI) - Market Newsdesk","og_description":"MENLO PARK, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) — Oruka Therapeutics, Inc. (\u201cOruka\u201d) (Nasdaq: ORKA), a biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including plaque psoriasis, today announced that it is expected to be added to the Nasdaq Biotechnology Index (Nasdaq: NBI) (the \u201cNBI\u201d). Oruka\u2019s addition will become effective prior to market open on Monday, December 23rd, 2024. The NBI is designed to track the performance of a set of securities listed on\u00a0The Nasdaq Stock Market\u00a0that are issued by companies classified as either biotechnology or pharmaceutical companies according to the Industry Classification Benchmark. Companies in the NBI must meet certain eligibility requirements, including, but not limited to, minimum market … Continue reading \"Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI)\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/oruka-therapeutics-to-be-added-to-the-nasdaq-biotechnology-index-nbi\/","og_site_name":"Market Newsdesk","article_published_time":"2024-12-18T12:04:52+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyMDg4NiM2NjQyMjA3IzIyOTAwOTk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oruka-therapeutics-to-be-added-to-the-nasdaq-biotechnology-index-nbi\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oruka-therapeutics-to-be-added-to-the-nasdaq-biotechnology-index-nbi\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI)","datePublished":"2024-12-18T12:04:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oruka-therapeutics-to-be-added-to-the-nasdaq-biotechnology-index-nbi\/"},"wordCount":285,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oruka-therapeutics-to-be-added-to-the-nasdaq-biotechnology-index-nbi\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyMDg4NiM2NjQyMjA3IzIyOTAwOTk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oruka-therapeutics-to-be-added-to-the-nasdaq-biotechnology-index-nbi\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/oruka-therapeutics-to-be-added-to-the-nasdaq-biotechnology-index-nbi\/","name":"Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI) - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oruka-therapeutics-to-be-added-to-the-nasdaq-biotechnology-index-nbi\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oruka-therapeutics-to-be-added-to-the-nasdaq-biotechnology-index-nbi\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyMDg4NiM2NjQyMjA3IzIyOTAwOTk=","datePublished":"2024-12-18T12:04:52+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oruka-therapeutics-to-be-added-to-the-nasdaq-biotechnology-index-nbi\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/oruka-therapeutics-to-be-added-to-the-nasdaq-biotechnology-index-nbi\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oruka-therapeutics-to-be-added-to-the-nasdaq-biotechnology-index-nbi\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyMDg4NiM2NjQyMjA3IzIyOTAwOTk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyMDg4NiM2NjQyMjA3IzIyOTAwOTk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oruka-therapeutics-to-be-added-to-the-nasdaq-biotechnology-index-nbi\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI)"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/795687","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=795687"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/795687\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=795687"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=795687"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=795687"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}